Accusations of insider trading and contractual breaches, nationalistic cries to keep the US giant at bay — what started as a spat has become a war and the battleground is the grocery business
From end-March 2020, the PIC had R1.907-trillion, or $125bn, in assets under management
The part-owner of upmarket malls says customers are returning but the uptake in sales is not enough to overcome lockdown losses
Both have, however, balked at a valuation of about $20bn demanded by Baidu and as both companies face scrutiny by China’s anti-trust regulators
SPONSORED | The farm is up for sale immediately, or on auction
The court ruled that Societe Generale failed to do proper due diligence before accepting Stanford’s money
SPONSORED | Improve financial controls and reduce the opportunities for fraud with Absa’s cash management team
In a German business newspaper op-ed, Herbert Diess likened VW to a ‘tanker’ amid the automotive world’s electrifying innovation
Huachen Group, which has defaulted on $987.48m in debt obligations, has angered investors who no longer have faith in the group, despite its state backing
Revenue in the first four months of Bidvest’s financial year are in line with that of 2019, with acquisitions and cost control offsetting the pandemic’s effects
Wealth managers are operating in a challenging environment, writes Pedro van Gaalen
Ren Zhengfei says Honor division should be free of US restrictions
The pandemic had little effect on the group’s ability to operate, saying it is benefiting from rapid demand for cloud-based services
Kaap Agri CEO Sean Walsh talks to Business Day TV about the group’s financial performance
The bank warns earnings could fall by a quarter to end-December
New baby product line and purchase of low-end clothing retailer Power Fashion could see it encroach on Pepkor’s territory
The latest cuts take the number of layoffs, mostly at Disney’s entertainment parks, to 32,000
SPONSORED | How NPOs can use tech to attract donors and make a bigger impact
CEO Pascal Soriot says he does not expect the additional trial to hold up regulatory approvals in the UK and EU, while clearance from the US FDA may take longer
Impairments, currency devaluation and restructuring costs hit the packaging company
